Brilique
Thousands to benefit with new anti-clotting drug recommendation, says NICE
August 12, 2016Medical Communications, Sales and Marketing AstraZeneca, Brilique, ticagrelor
The National Institute for Health and Care Excellence (NICE) has published new draft guidance recommending AstraZeneca’s Brilique (ticagrelor) for people …
Three AstraZeneca drugs recommended by EMA committee
December 21, 2015Sales and Marketing AstraZeneca, Brilique, CHMP, EMA, Portrazza, Tagrisoo, lesinurad, lilly
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended several new drugs in its latest meeting, including …
Brilique recommended for use by Germany’s pricing watchdog
December 19, 2011Sales and Marketing AstraZeneca, Brilique, Plavix
Germany’s new pricing committee has said that AstraZeneca’s Brilique is a cost effective treatment for patients with a certain heart …
Key product launches of 2011
December 19, 2011Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Actos, Benlysta, Brilique, Eliquis, Eylea, Incivek, Jevtana, Multaq, Victrelis, Xalkori, Yervoy, Zytiga, avastin, gilenya, key products
Avastin 2011 saw a handful of high profile drugs suffer because of new safety and efficacy concerns. Chief among these …
Brilique gains NICE approval
October 31, 2011Sales and Marketing ACS, Brilique, NICE, Plavix, clopidogrel
AstraZeneca’s Brilique has been approved by NICE for use in combination with aspirin as an option to treat patients with …
FDA approves AstraZeneca’s Brilinta after delay
July 21, 2011Sales and Marketing AstraZeneca, Brilinta, Brilique, antiplatelet
The FDA has finally approved AstraZeneca’s oral blood thinner Brilinta after asking for more information on the drug last year. …
FDA delays approval of AstraZeneca’s Brilinta
December 20, 2010Research and Development, Sales and Marketing AZ, AstraZeneca, Brilinta, Brilique, acute coronary syndrome
US regulators have delayed approving AstraZeneca’s antiplatelet tablet Brilinta (ticagrelor) because their want more information about a crucial clinical trial. …
AZ’s Brilique approved in Europe
December 7, 2010Sales and Marketing AZ, AstraZeneca, Brilique, Plavix, acute coronary syndromes, antiplatelet, atherothrombotic events, ticagrelor
European regulator have approved AstraZeneca’s oral antiplatelet Brilique (ticagrelor tablets). Brilique can now be used for the prevention of atherothrombotic …
AZ plans heart attack study for Brilique
October 8, 2010Research and Development, Sales and Marketing AstraZeneca, Brilinta, Brilique
AstraZeneca is due to begin enrolling patients into a new study of its oral antiplatelet Brilique (ticagrelor) before the end …
AZ’s antiplatelet recommended for European approval
September 27, 2010Sales and Marketing Brilinta, Brilique, Brillinta, Possia
AstraZeneca’s oral antiplatelet treatment Brilique has received a positive opinion from a key European advisory committee. A marketing authorisation for …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
